Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study

LEFVERT, 1978, Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications, J Neurol Neurosurg Psych, 41, 394, 10.1136/jnnp.41.5.394

STANLEY, 1978, Effect of myasthenic immunoglobulinon acetylcholine receptors of intact mammalian neuromuscular junctions, Science, 200, 1285, 10.1126/science.663610

BRUNNER, 1972, Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy, Neurology, 22, 603, 10.1212/WNL.22.6.603

MANN, 1976, Long-term prednisone followed by thymectomy in myasthenia gravis, Ann NY Acad Sci, 274, 608, 10.1111/j.1749-6632.1976.tb47719.x

JENKINS, 1972, Treatment of myasthenia gravis with prednisone, Lancet, i, 765, 10.1016/S0140-6736(72)90520-X

PASCUZZI, 1984, Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients, Ann Neurol, 15, 291, 10.1002/ana.410150316

SGHIRLANZONI, 1984, Myasthenia gravis: prolonged treatment with steroids, Neurology, 34, 170, 10.1212/WNL.34.2.170

EVOLI, 1992, Long-term results of corticosteroid therapy in patients with myasthenia gravis, Eur Neurol, 32, 37, 10.1159/000116785

PINELLI, 1974, Long-term treatment of myasthenia gravis with alternate-day prednisone, Eur Neurol, 12, 129, 10.1159/000114612

MATELL, Effects on myasthenia of twin shock doses of methyl prednisolone (TSDMP)

ARSURA, 1985, High-dose intravenous methylprednisolone in myasthenia gravis, Arch Neurol, 42, 1149, 10.1001/archneur.1985.04060110031011

OSTERHUIS, 1981, MG. A review, Clin Neurol Neurosurg, 83, 105

LEFVERT, 1987, Idiotypes and antiidiotypes of human autoantibodies to the acetylcholine receptor, Monogr Allergy, 22, 57

WARMOLTS, 1972, Benefit from alternate-day prednisone in myasthenia gravis, N Engl J Med, 286, 17, 10.1056/NEJM197201062860104

MILLER, 1986, Prednisone induced worsening of neuromuscular function in myasthenia gravis, Neurology, 36, 729, 10.1212/WNL.36.5.729

OLSSON, 1994, Centrolobular liver-cell necrosis, myocardial infarction and hyperamylasaemia after high dose corticosteroids, BMJ, 308, 454, 10.1136/bmj.308.6926.454

LYONS, 1988, Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects, J Neurol Neurosurg Psychiatry, 51, 285, 10.1136/jnnp.51.2.285

PANEGYRES, 1993, Acute myopathy associated with large parental dose of corticosteroid in myasthenia gravis, J Neurol Neurosurg Psychiatry, 56, 702, 10.1136/jnnp.56.6.702

NEEDS, 1988, Comparison of Methylprednisolone (1 g IV) with Prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study, J Rheumatol, 15, 224

MILLIGAN, 1987, COMPSTON DAS. A double-blind controlled trial of high-dose intravenous methylprednisolone in patients with multiple sclerosis. I. Clinical effects, J Neurol Neurosurg Psychiatry, 50, 511, 10.1136/jnnp.50.5.511

WEUSTEN, 1993, Corticosteroid pulse therapy in active rheumatoid arthritis, Semin Arthritis Rheum, 23, 183, 10.1016/S0049-0172(05)80039-3

ÅHLBERG, 1994, Treatment of myasthenia gravis with anti-CD4 antibody: Improvement correlates to changes in T-cell reactivity, Neurology, 44, 1732, 10.1212/WNL.44.9.1732

GROB, 1995, Treatment of myasthenia gravis by immunoadsorption of plasma, Neurology, 45, 338, 10.1212/WNL.45.2.338

COSI, 1991, Treatment of myasthenia gravis with high-dose intravenous immunoglobulin, Acta Neurol Scand, 84, 81, 10.1111/j.1600-0404.1991.tb04912.x

TINDALL, 1993, A clinical therapeutic trial of cyclosporine in myasthenia gravis, Ann NY Acad Sci, 681, 539, 10.1111/j.1749-6632.1993.tb22937.x